In vitro generation of bacillus Calmette-Guérin-activated killer cells.

Tumor regression induced in cancer patients by local instillation of bacillus Calmette-Guérin (BCG) into the bladder is considered to be mediated by cellular immune and inflammatory reactions. In an attempt to elucidate which of these effects are relevant to tumoricidal activity, an in vitro system was employed in which the immunostimulatory effects of BCG could be studied. This report describes the induction of BCG-activated killer (BAK) cells, which effectively lyse bladder tumor cells. Human peripheral blood mononuclear cells (PBMC) were stimulated with viable and sonicated BCG (v-BCG and s-BCG, respectively) to generate BAK cells. Cytotoxicity of BAK cells was comparable with the cytotoxicity exerted by lymphokine-activated killer (LAK) cells generated by interferon (IFN)-gamma but did not reach the level of interleukin-2 (IL-2)-generated LAK cells. Induction of BAK cells was possible only with v-BCG and not with s-BCG. By depletion and enrichment of defined cell populations, the cytotoxic potential of BAK cells could be attributed to a population of CD8(+) and CD56(+) double-positive lymphocytes. Macrophages and CD4(+) cells were required for the induction of killing activity but had no such activity by themselves. Furthermore, the presence of IFN-gamma and IL-2 in the supernatants harvested during the generation of BAK cells was demonstrated. Monoclonal antibodies neutralizing these cytokines abolished BCG-mediated cytotoxicity. From these results, it is concluded that the known beneficial effect of local instillation of BCG on maintenance of the relapse-free state in superficial bladder cancer may be due to local generation of BAK cells.

[1]  Dirk Lorenzen,et al.  Phenotypical and functional characterization of Fey receptor I (CD64)‐negative monocytes, a minor human monocyte subpopulation with high accessory and antiviral activity , 1993, European journal of immunology.

[2]  W. Catalona,et al.  T-cell subsets required for intravesical BCG immunotherapy for bladder cancer. , 1993, The Journal of urology.

[3]  S. Prescott,et al.  An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cancer cell lines. , 1992, The Journal of urology.

[4]  R. Pollock,et al.  Antitumor activity, growth, and phenotype of long-term IL-2 cultures of human NK and T lymphocytes. , 1991, Lymphokine and cytokine research.

[5]  H. Flad,et al.  Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines. , 1991, Immunology letters.

[6]  J. Smyth,et al.  Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. , 1990, The Journal of urology.

[7]  J. Gerdes,et al.  Effects of local bacillus Calmette-Guerin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. , 1990, The Journal of urology.

[8]  J. Gerdes,et al.  Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus Calmette-Guerin immunotherapy. , 1990, The Journal of urology.

[9]  M. Schlaak,et al.  Density-dependent tumor cell death and reversible cell cycle arrest: mutually exclusive modes of monocyte-mediated growth control. , 1990, Experimental cell research.

[10]  R. Finberg,et al.  Human γδ+ T cells respond to mycobacterial heat-shock protein , 1989, Nature.

[11]  W. Catalona,et al.  Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. , 1987, The Journal of urology.

[12]  W. Catalona,et al.  Detection of interleukin 2 in the urine of patients with superficial bladder tumors after treatment with intravesical BCG. , 1986, The Journal of urology.

[13]  J. Ortaldo,et al.  Lymphokine-activated killer cells. Analysis of progenitors and effectors , 1986, The Journal of experimental medicine.

[14]  M. Ernst,et al.  Dissociation of responses measured by natural cytotoxicity and chemiluminescence , 1984, European journal of immunology.

[15]  S. Rosenberg,et al.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer- resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes , 1982, The Journal of experimental medicine.

[16]  W. Leibold,et al.  75Se-release: a short and long term assay system for cellular cytoxicity. , 1979, Zeitschrift fur Immunitatsforschung. Immunobiology.

[17]  N. Axelsen,et al.  Antibody response in rabbits to immunization with Mycobacterium leprae , 1977, Infection and immunity.

[18]  Elizabeth Simpson,et al.  A rapid method for the isolation of functional thymus‐derived murine lymphocytes , 1973, European journal of immunology.